HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glucosylceramide modulates membrane traffic along the endocytic pathway.

Abstract
Glycosphingolipids are endocytosed and targeted to the Golgi apparatus, but are mistargeted to lysosomes in numerous sphingolipidoses. Substrate reduction therapy utilizes imino sugars to inhibit glucosylceramide synthase and potentially abrogate the effects of storage. Gaucher disease is a hereditary deficiency in glucocerebrosidase leading to glucosylceramide accumulation; however, Gaucher fibroblasts exhibited normal Golgi transport of lactosylceramide. To better understand the effects of glycosphingolipid accumulation on intracellular trafficking and the use of imino sugar inhibitors, we studied sphingolipid endocytosis in fibroblast and macrophage models for Gaucher disease. Treatment of fibroblasts or RAW macrophages with conduritol B epoxide, an inhibitor of lysosomal glucocerebrosidase, resulted in a change in the endocytic targeting of lactosylceramide from the Golgi to the lysosomes. Co-treatment of macrophages with conduritol B-epoxide and 12-25 microM N-butyldeoxygalactonojirimycin, an inhibitor of glycosphingolipid biosynthesis, prevented the mistargeting of lactosylceramide to the lysosomes and restored trafficking to the Golgi. Surprisingly, higher doses (>25 microM) of NB-DGJ induced targeting of lactosylceramide to the lysosomes, even in the absence of conduritol B-epoxide. These data demonstrate that both increases and decreases in glucosylceramide levels can dramatically alter the endocytic targeting of lactosylceramide and suggest a role for glucosylceramide in regulation of membrane transport.
AuthorsDan J Sillence, Vishwajeet Puri, David L Marks, Terry D Butters, Raymond A Dwek, Richard E Pagano, Frances M Platt
JournalJournal of lipid research (J Lipid Res) Vol. 43 Issue 11 Pg. 1837-45 (Nov 2002) ISSN: 0022-2275 [Print] United States
PMID12401882 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene
  • Boron Compounds
  • Fluorescent Dyes
  • Glucosylceramides
  • Lactosylceramides
  • Psychosine
  • sphingosyl beta-glucoside
  • Sphingosine
Topics
  • Biological Transport (drug effects)
  • Boron Compounds
  • Cell Membrane (drug effects)
  • Dose-Response Relationship, Drug
  • Endocytosis (drug effects)
  • Fibroblasts (drug effects, metabolism, pathology)
  • Fluorescent Dyes
  • Gaucher Disease (pathology)
  • Glucosylceramides (metabolism, pharmacology)
  • Humans
  • Lactosylceramides (metabolism, pharmacology)
  • Macrophages (drug effects, metabolism, pathology)
  • Psychosine (analogs & derivatives)
  • Solubility
  • Sphingosine (analogs & derivatives, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: